<DOC>
	<DOCNO>NCT02254928</DOCNO>
	<brief_summary>A randomised , crossover , multicentre , national , clinical trial compare efficacy corifollitropin alfa versus daily recombinant FSH HMG control ovarian stimulation woman poor ovarian response undergo IVF treatment . The main objective study compare number oocyte obtain follicle puncture use two stimulation protocol . Only poor responder accord Bologna criterion recruit trial . All participant undergo two stimulation cycle obtain accumulate oocyte vitrification . One cycle do corifollitropin alfa protocol daily rFSH HMG , order application protocol randomise ( crossover clinical trial ) patient .</brief_summary>
	<brief_title>Corifollitropin Alfa Versus Daily rFSH Controlled Ovarian Stimulation Poor Responders</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>Advanced maternal age ( ≥40 year ) A previous poor ovarian response ( ≤3 oocytes conventional stimulation protocol ) An abnormal ovarian reserve test ( i.e . antral follicle count &lt; 57 follicle antimullerian hormone level &lt; 0.51.1 ng/ml )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>poor ovarian response</keyword>
	<keyword>control ovarian stimulation</keyword>
	<keyword>randomised clinical trial</keyword>
	<keyword>corifollitropin alfa</keyword>
	<keyword>recombinant follicle-stimulating hormone ( rFSH )</keyword>
	<keyword>human menopausal gonadotropin ( HMG )</keyword>
</DOC>